Home|Journals|Articles by Year|Audio Abstracts
 

Review Article

AAM. 2021; 10(2): 135-147


Therapeutic potential of Withania somnifera (Linn) Dunal (Ashwagandha) in historical perspective and pharmacological evidence

Krishnapriya Santhanu, Kalaiselvi Senthil.




Abstract

Withania somnifera widely known as Aswagandha, highly acclaimed medicine in ancient medical systems such as Ayurveda, Unani, Siddha and Chinese traditional medicine. The pharmacological importance of Withania somnifera is described in the different classical Ayuvedic narrative such as Charaka Samhita, Sushruta Samhita, Astangahridaya, Chakaradatta and various Nighantus. The plant used for the treatment of various ailments and works as nonspecific basis for better health and finer longevity. Nowadays it is scientifically proved that the plant possesses antioxidant activity, protect from anxiety and depression, nootropic effect, cardiovascular protection, anti-bacterial activity, anti-inflammatory properties, aphrodisiac,a nti-venom, anti-fungal, anti-viral, sedative effects, hypoglycemic, thyro-protective, anti-diabetic and different cancer.This study aims to review and relist the various therapeutic applications of this plant and its importance in Ayurveda as per ancient classical texts.

Key words: Aswagandha, Ayurvedic formulations, Ayurvedic reference, Therapeutic indications, Withania Somnifera.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.